Koller, T.O.* ; Scheid, U.* ; Kösel, T.* ; Herrmann, J.* ; Krug, D.* ; Boshoff, H.I.M.* ; Beckert, B.* ; Evans, J.C.* ; Schlemmer, J.* ; Sloan, B.* ; Weiner, D.M.* ; Via, L.E.* ; Moosa, A.* ; Ioerger, T.R.* ; Gräf, M.* ; Zinshteyn, B.* ; Abdelshahid, M.* ; Nguyen, F.* ; Arenz, S.* ; Gille, F.* ; Siebke, M. ; Seedorf, T.* ; Plettenburg, O. ; Green, R.* ; Warnke, A.-L. ; Ullrich, J.* ; Warrass, R.* ; Barry, C.E.* ; Warner, D.F.* ; Mizrahi, V.* ; Kirschning, A.* ; Wilson, D.N.* ; Müller, R.*
The
myxobacterial antibiotic myxovalargin: Biosynthesis, structural
revision, total synthesis and molecular characterization of ribosomal
inhibition.
J. Am. Chem. Soc. 145, 851-863 (2023)
Resistance of bacterial pathogens against antibiotics is declared by WHO as a major global health threat. As novel antibacterial agents are urgently needed, we re-assessed the broad-spectrum myxobacterial antibiotic myxovalargin and found it to be extremely potent against Mycobacterium tuberculosis. To ensure compound supply for further development, we studied myxovalargin biosynthesis in detail enabling production via fermentation of a native producer. Feeding experiments as well as functional genomics analysis suggested a structural revision, which was eventually corroborated by the development of a concise total synthesis. The ribosome was identified as the molecular target based on resistant mutant sequencing, and a cryo-EM structure revealed that myxovalargin binds within and completely occludes the exit tunnel, consistent with a mode of action to arrest translation during a late stage of translation initiation. These studies open avenues for structure-based scaffold improvement toward development as an antibacterial agent.
Altmetric
Weitere Metriken?
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Korrespondenzautor
Schlagwörter
Beam-induced Motion; Cryo-em Structure; Antimicrobial Peptide; Mechanism; Discovery; Defocus; Family
Keywords plus
ISSN (print) / ISBN
0002-7863
e-ISSN
1520-5126
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 145,
Heft: 2,
Seiten: 851-863
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
American Chemical Society (ACS)
Verlagsort
1155 16th St, Nw, Washington, Dc 20036 Usa
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Medicinal Chemistry (IMC)
Förderungen
Bill and Melinda Gates Foundation
Deutsche Forschungsgemeinschaft (DFG)
MEYS CR
iNEXT
Intramural Research Program of NIAID/NIH
National Research Foundation of South Africa
South African Medical Research Council
Bill & Melinda Gates Foundation